by Julia Cardi Credit: Unsplash/CC0 Public Domain A new device is now available for treating advanced liver cancer at home using electromagnetic waves, the Barbara Ann Karmanos Cancer Institute announced. Called the “TheraBionic P1,” the device works via a small spoon-shaped antenna the patient places on their tongue, said co-inventor Dr. Boris Pasche at a...
Tag: <span>Liver cancer</span>
Post
Model can predict, stratify liver cancer risk in noncirrhotic chronic hepatitis B
September 18, 2024 by Elana Gotkine A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with chronic hepatitis B (CHB), according to a study published online Sept. 17 in the Annals of Internal Medicine. Gi-Ae Kim, M.D., Ph.D., from Kyung Hee University Hospital in Seoul, South Korea, and...
Post
RARE LIVER CANCER HAS SURPRISING ORIGINS
JUNE 24TH, 2024POSTED BY ROCKEFELLER UNIVERSITY A microscopy image of single cell spatial transcriptomics of FLC tumor cells (red) and stellate cells (green); the latter generates fibrous bands of collagen in response to the FLC cells. (Credit: Rockefeller) TAGS : CANCERLIVERSUNIVERSITY : ROCKEFELLER UNIVERSITY New research sheds light on a rare form of cancer called...
Post
Research team uses AI to predict risk of liver cancer
by UC Davis Credit: Pixabay/CC0 Public DomainA team of UC Davis Health clinicians and data scientists has developed a machine-learning model to better predict which patients are at greater risk of developing a common type of liver cancer, hepatocellular carcinoma (HCC). The findings of their research—published in the journal Gastro Hep Advances—describe how predictive-learning can aid...
Post
Treating liver cancer with microrobots
The idea of injecting microscopic robots into the bloodstream to heal the human body is not new. It’s also not science fiction. Guided by an external magnetic field, miniature biocompatible robots, made of magnetizable iron oxide nanoparticles, can theoretically provide medical treatment in a very targeted manner. Until now, there has been a technical obstacle:...
Post
For diabetes and liver cancer, study suggests new screening guidelines
by Krista Conger, Stanford University Medical Center Collagen fibers in a three-dimensional hydrogel (left panel). When advanced glycation end products—a byproduct of poorly controlled diabetes—are added (right), the fibers are shorter and more cross-linked, creating conditions that favor cancer progression. Credit: Weiguo FanFor centuries, doctors have used their hands as essential diagnostic tools—exploring joints and palpating...
Post
Liver cancer rates increase in each successive generation of Mexican Americans, study finds
The research, led by the Keck School of Medicine of USC, analyzed risk for the disease across more than 30,000 Mexican Americans, finding third-generation Mexican Americans 66% more likely to get liver cancer than the first generation.Peer-Reviewed Publication KECK SCHOOL OF MEDICINE OF USC In the United States, liver cancer rates have more than tripled...
Post
Gene therapy study identifies potential new treatment for liver cancer
by UC Davis Graphical Abstract. Credit: Molecular Therapy (2023). DOI: 10.1016/j.ymthe.2023.04.019 Gene therapy that induces the body to create microRNA-22 (miR-22), a naturally occurring molecule, successfully treated mice with hepatocellular carcinoma, the most common form of liver cancer. The miR-22 treatment also reduced liver inflammation and produced better survival outcomes with no observable toxicity compared...
Post
Study reveals a trio of immune cells vital in response to liver cancer immunotherapy
by The Mount Sinai Hospital The study revealed how certain immune cell interactions in tumors facilitate response to checkpoint blockade, pointing to potential new approaches to cancer immunotherapy. Credit: Magen et al., Nature Medicine Researchers at the Icahn School of Medicine at Mount Sinai have uncovered a trio of immune cells within tumor niches that are associated with...
Post
Epigenetic mechanism associated with clinical outcome and therapeutic vulnerability in liver cancer
by Josep Carreras Leukaemia Research Institute NSUN7 epigenetic loss occurs in human primary HCC tumors in association with worse clinical outcome. (A) Percentage of NSUN7 methylation in the TCGA data set of primary tumors according to cancer type. (B) NSUN7 methylation is inversely correlated with NSUN7 transcript expression in TCGA HCC tumors. (C) NSUN7 methylation is...